| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/12/2004 | WO2002034893A3 Synthetic viruses and uses thereof |
| 02/12/2004 | US20040030117 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029251 Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture |
| 02/12/2004 | US20040029250 Method and device for sanitation using bacteriophages |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040028701 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 02/12/2004 | US20040028698 Vaccine |
| 02/12/2004 | US20040028652 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
| 02/12/2004 | CA2493791A1 Large circular sense molecule array |
| 02/11/2004 | EP1387694A2 Composition and method for treating cancer using herpes virus |
| 02/11/2004 | EP0655072B1 Immunological method for the detection of antibodies to equine herpesvirus type 1 and 4 glycoprotein G |
| 02/11/2004 | CN1473933A Beet black withered virus as expression carrier of foreigh gene |
| 02/11/2004 | CN1137993C Recombinant adenovirus of bone morphogenetic protein and its method for exciting bone generation |
| 02/10/2004 | US6689884 Supramolecular pairing system, its preparation and use |
| 02/10/2004 | US6689879 Nucleotide sequences coding nvelope protein for use in the prevention of viral diseases |
| 02/10/2004 | US6689559 Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |
| 02/10/2004 | US6689367 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 02/10/2004 | US6689366 Conformational epitope; characterization of human papillomavirus infection; vaccines |
| 02/05/2004 | WO2004011677A2 Viral marker |
| 02/05/2004 | WO2004011490A1 A immounlogical epitope of the hiv strain type o and the uses thereof |
| 02/05/2004 | WO2004011489A2 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
| 02/05/2004 | WO2003097089A3 Attenuation of metapneumovirus |
| 02/05/2004 | WO2003077853A3 Immortal porcine cells |
| 02/05/2004 | WO2003059944A3 Gb virus b based replicons and replicon enhanced cells |
| 02/05/2004 | WO2003059292A3 Composition and method for maintaining non-enveloped viral vectors |
| 02/05/2004 | WO2003052052A3 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2002072776A3 Cell culture system for synthesis of infectious hepatitis c virus |
| 02/05/2004 | US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 02/05/2004 | US20040023358 Avian embryo particulate biomass for the production of virus antigens |
| 02/05/2004 | US20040023205 Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material |
| 02/05/2004 | US20040022812 Herpes viruses for immune modulation |
| 02/05/2004 | US20040022809 Cold-adapted equine influenza viruses |
| 02/05/2004 | DE10233064A1 gM-negative EHV-Mutanten ohne heterologe Elemente gM-negative EHV mutants without heterologous elements |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1385968A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants |
| 02/04/2004 | EP1385555A1 Viral vectors having reduced virulence |
| 02/04/2004 | EP1385540A2 Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 02/04/2004 | EP1385466A2 Oncolytic virus therapy |
| 02/04/2004 | EP1385370A2 Animicrobial polypeptides and their uses |
| 02/04/2004 | EP0842287B1 High efficiency helper system for aav vector production |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | CN1472315A Expression of larynogotracheitis or epiornitic virus gene recombined varicella virus and its use |
| 02/04/2004 | CN1472314A Immunity expression of AIDS virus O and its use |
| 02/04/2004 | CN1136920C Gene transfer-mediated angiogenesis therapy |
| 02/03/2004 | US6686200 Methods and compositions for the large scale production of recombinant adeno-associated virus |
| 02/03/2004 | US6686190 Methods for enhancing the production of viral vaccines in cell culture |
| 02/03/2004 | US6685948 Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines |
| 02/03/2004 | US6685946 Cold-adapted equine influenza viruses |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 01/29/2004 | WO2004009802A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 01/29/2004 | WO2004009768A2 Viral vectors containing recombination sites |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009032A2 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2004008938A2 A novel method to identify targets for antibiotic development |
| 01/29/2004 | WO2003066663A3 Peptides for recognition and targeting of glial cell tumors |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | US20040018627 High-efficiency AAV helper functions |
| 01/29/2004 | US20040018211 EIA vaccine and diagnostic |
| 01/29/2004 | US20040018208 A part of the coding sequence of the middle glycoprotein of the hepatitis B virus, which has a dna sequence coding for at least one tumor epitope of a tumor antigen inserted |
| 01/29/2004 | DE19952982B4 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 01/29/2004 | CA2493406A1 Gm-negative ehv-mutants without heterologous elements |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/28/2004 | EP1383796A1 Neurovirulent strain of the west nile virus and applications thereof |
| 01/28/2004 | EP1383795A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/28/2004 | EP1383782A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471580A Virus Particles with exogenous internal eitopes |
| 01/28/2004 | CN1136011C Method and apparatus for inactivating contaminants inbiological fluid |
| 01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
| 01/27/2004 | US6682929 Adenovector complementing cells |
| 01/27/2004 | US6682907 Lentivirus have the unique capacity among retroviruses of infecting differentiated non mitotic cells and represent viral candidates of interest for the development of novel vectors |
| 01/27/2004 | US6682743 Genetically engineered virus for use in the propagation of preferential cells |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/22/2004 | WO2004007735A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | WO2004007703A1 Replicability virus which can express anti-tumour antibody with high efficiency and the use of it |
| 01/22/2004 | WO2004007538A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 01/22/2004 | WO2004007537A2 Modified adenoviral fiber with ablated to cellular receptors |
| 01/22/2004 | WO2002088339A3 Bursal disease virus-like particles |
| 01/22/2004 | US20040014219 Comprises expression vector coding fusion protein associated cell proliferation and/or differentiation; gene therapy; animal model for disease |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014046 Preparing candidate vaccine agents based on a polypeptide comprising an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide that induces an immune response |
| 01/22/2004 | US20040014033 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2491805A1 Modified adenoviral fiber with ablated binding to cellular receptors |
| 01/22/2004 | CA2489410A1 Molecular antigen arrays |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1381675A2 Method for replicating the hepatitis c virus |
| 01/21/2004 | EP1381673A1 Compositiona and methods useful for hcv infection |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381389A1 Smallpox vaccine |
| 01/21/2004 | EP1381388A1 Production of peptides in plants as n-terminal viral coat protein fusions |
| 01/21/2004 | EP1381280A1 Viral vectors and their use in therapeutic methods |
| 01/21/2004 | EP0863982B1 Synthetic hpv11 virus-like particles |
| 01/21/2004 | CN1469930A Cytomegalovirus intron a fragments |